Chlamydia pneumoniae antibodies in severe essential hypertension

Hypertension

Volumn 31, Issue 2, 1998, Pages 589-594

  Cook, P J ^a   Lip, G Y H ^b   Davies, P ^c   Beevers, D G ^d   Wise, R ^e   Honeybourne, D ^b  

^a Department of Thoracic Medicine ^*  (United Kingdom)

^b University Department of Medicine   (United Kingdom)

^c CITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular diseases; Hypertension, essential; Infection

Indexed keywords

D DIMER; FIBRINOGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM;

EID: 0031910856     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.2.589     Document Type: Article

References (59)

1. GraystonJT, Kuo CC, Wang SP, AltmanJ. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. /V EnglJ Med. 1986; 315:161-168.
2. Wang SP, Grayston JT. Micro-immunofluorescence serological studies with the TWAR organism. In: Oriel JD, Ridgway GL, Schachter J, Taylor-Robinson D, Ward ME, eds. Chlamydial Injections. Cambridge, UK: Cambridge University- Press; 1986:329-332.
3. Forsey T, Darougar S, TreharneJD, Jones BR, Herring AJ. Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of Chlamydia. J Inject. 1986;12:145-152.
4. Kanamoto Y, Ouchi K, Mizui M, Ushio M, Usui T. Prevalence of antibody to Chhmydia pneumonia? TWAR in Japan. J din Microbiol. 1991; 29:816-818.
5. Montes M, Cilla G, Alcorta M, Pérez-Trallero E. High prevalence of Clilainydia pneuiiwniae infection in children and young adults in Spain. Pcdiatr Inject Dis]. 1992;! 1:972-973.
6. Cook PJ, Honeybourne D. Clinical aspects of Chhmydia pncumoniae infection. Presse Mcd. 1995;24:278-282.
7. Saikku P, Leinonen M, Mattila KJ, Ekman MR, Nieminen MS, Mäkela PH, HuttunenJK, Valtonen VV. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983-986.
8. Thorn DH, GraystonJT, Siscovick DS, Wang SP, Weiss NS, DalingJR. Association of prior infection with Chhmydia pncumoniae and angiographically demonstrated coronary artery disease. JAMA. 1992;268:68-72.
9. Dahlen DH, BomanJ, Birgander LS, Lindblom B. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumonias and HLA class II genotype in early coronary artery disease. Atherosclerosis. 1995;114:165-174.
10. Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levi J, Toosey T, Camm AJ, Northfield TC. Chlamydia pneiimoniae: risk factors for seropositivity and association with coronary heart disease. J Infect. 1995;30: 21-28.
11. Cook PJ, Lip GYH, Beevers DG, Honeybourne D, Wise R. Elevated Chlamydia pncumoniae antibody titers are associated with acute stroke syndromes. Circulation. 1995;92(suppl l):482-483.
12. Melnick SL, Shahar E, Folsom AR, Grayston JT, Sortie PD, Wang SP, Szklo M. Past infection by Chlamydia pncumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med. 1993;95:499-504.
13. 12a.Devereux RB, Reichert N. Echocardiographic determination ofleft ventricular mass in man: anatomic validation of the method. Circulation. 1977; 55:613.
14. 12b.Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1078-1083.
15. 12c.Koren MJ, Devereux RB. Risk, recognition and reversal ofleft ventricular hypertrophy in hypertension. Citrr Opin Cardiol. 1991:6:710-715.
16. 12d.Sokolow M, Lyon TR. The ventricular complex in left ventricular hypertrophy as observed by unipolar and limb leads. Am Heart J. 1949;37: 161-186.
17. Townsend P, Phillimore P, Beattie A. Health and Deprivation. London, England: Routledge; 1989.
18. Mahony JB, Chemesky MA, Bromberg K, Schachter J. Accuracy of immunoglobulin M immunoassay for diagnosis of chlamydial infections in infants and adults. J Clin .Microbiol. 1986;24:731-735.
19. Grayston JT, Mordhorst CH, Bruu AL, Vene S, Wang SP. Country-wide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983.J 'Jett Dis. 1989;159:1111-1114.
20. Chirgvin K, Roblin PM, Gelling M, Hammerschlag MR, Schachter J. Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis. 1991;163: 757-761.
21. Hulley SB, Cummings SR. Designing Clinical Research. Baltimore, Md: Williams & Wilkins; 1988:216-217.
22. Statistics, and Epidemiology Research Corporation S 98015 U.S.A. EGRET Statistical and Epidemiological Research Package.
23. Verkooyen RP, Hazenberg MA, van Haaren GH, van den Bosch JM, Snijder RJ, van Helden HP, Verbrugh HA. Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor. J Clin Microbiol. 1992;30:1287-1290.
24. Bames RJ, UlT JS, Dent JC, Gear MW, Wilkinson SP. Long-term follow-up of patient with gastritis associated with Helicobacter pylori infection. BrJ Gen Pract. 1991:41:286-288.
25. Schreiber MD, Covert RF, Torgerson LJ. Hemodynamic effects of heatkilled group B beta-haemolytic streptococcus in newborn lambs: role of leukotriene D4. Pediatr Res. 1992:31:121-126.
26. Cook PJ, Honeybourne D, Wise R, Davies P. Chlamydia p'ieiimoniae antibody titres are significantly associated with Afro-Caribbean and Asian origin. Eur RcspirJ. 1996;9(suppl 23):326S.
27. Paltiel O, KarkJD, Leinonen M, Saikku P. High prevalence of antibodies to Chlamydia pneumoniae: determinants of IgG and IgA seropositivity among Jerusalem residents. Epidetniol Infect. 1995;! 14:465-473.
28. Karvonen M, Tuomilehto J, Pitkaniemi J, Naukkarinen A, Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epi~ demiol. 1994;23:1315-1321.
29. Hahn DL, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscl Tliromb. 1992:12:945-947.
30. Sonkodi S, Rednik A, Kovâcs A. Correlations of the fibrinogen level with the blood pressure and with the plasma renin activity in hypertensive patients. Cor Vasa. 1979;21:228-232.
31. Memeh CU. The relationship between body weight and plasma viscosity in hypertensive diabetic Nigerians. J Hypenens. 1990;8:711-714.
32. Lip GYH, Beevers DG. Abnormalities of rheology and coagulation in hypertension. J Hum Hypertem. 1994;8:693-702.
33. Ameriso SF, Wong VL, Quismorio FP, Fisher M. Immunohematological characteristics of infection-associated cerebral infarction. Stroke. 1991;22: 1004-1009.
34. Yarnell JWG, Baker IA, Sweetman PM, Bainton PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischémie heart disease. Circulation. 1991:83:836-844.
35. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993;! 18:956-963.
36. Lip GYH, Lowe GDO. Fibrin D-dimer: a useful clinical marker of thrombogenesis in vascular disorders? Clin Sei. 1995:89:205-214.
37. Cook PJ, Honeybourne D. Chlamydia pneumoniae. J Antimicrob Chcmoiher. 1994:34:859-873.
38. Wang SP, Grayston JT. Human serology in Chlamydia trachomatis infection with micro-immunofluorescence. J Inject Dis. 1974:130:388-397.
39. Csangö PA, Sarov B, Schiotz H, Sarov I. Comparison between cell culture and serology for detecting Chlamydia trachomatis in women seeking abortion. J Clin Pathol. 1988;41:89-92.
40. Darougar S, Forsey T, Brewerton DA, Rogers LI. Prevalence of antichlamydial antibody in London blood donors. BrJ l'en Dis. 1980;56: 404-407.
41. Moss TR, Darougar S, Woodland RM, Nathan M, Dines RJ, Cathrine V. Antibodies to Chlamydia species in patients attending a genitourinary clinic and the impact of antibodies to C. pneumottiae and C. psiltaci on the sensitivity and the specificity of C. tradiomatis serology tests. Sex Tratism Dis. 1993:20:61-65.
42. Thorn DH, Grayston JT. Infections with Chlamydia pneumonias strain TWAR. Clin Chest Med. 1991:12:245-256.
43. Beaty CD, Grayston JT, Wang SP, Kuo CC, Reto CS, Martin TR. Chlamydia pneiimoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991;144:1408-1410.
44. Kleemola M, Saikku P, Visakorpi R, Wang SP, Grayston JT. Epidemics of pneumonia caused by TWAR, a new Chlatnydia organism, in military trainees in Finland. J Infect Dis. 1988;157:230-236.
45. Saikfcu P, Ruutu P, Leinonen M, Panelius J, Tupasi TE, Grayston JT. Acute lower respiratory tract infection associated with chlamydial TWAR antibody in Filipino children. J Infect Dis. 1988:158:1095-1097.
46. Mordhorst CH, Wang SP, Myhra W, Grayston JT. Clilamydia pnettnioniae, strain TWAR, infections in Denmark, 1975-1987. In: Bowie WR, Caldwell HD, Jones RP, Mîrdh PE, Ridgway GL, Schachter J, Stamm WE, Ward ME, eds. Chlamydial Infections. Cambridge, UK: Cambridge University Press; 1990:418-421.
47. Thorn DH, Grayston JT, Wang SP, Kuo CC, Altman J. Chlamydia pneumoniae strain TWAR, Mycoplasma pneiimoniae and viral infections in acute respiratory disease in a university student health clinic population. Am J Epidemiol. 1990;161:248-256.
48. Berdal BP, Scheel O, Ygaard AR, Hoel T, Gutteberg TJ, Anestad G. Spread of subclinical Chlamydia pneiimoniae infection in a closed community. Sana J Infect Dis. 1992;24:431-436.
49. Ozanne G, Lefebvre J. Specificity of the micro-immunofluorescence assay for the serodiagnosis of Chlamydia pneumonia? infections. Can J Alicrobiol. 1992;38:1185-1189.
50. Ekman MR, Grayston JT, Visakorpi R, Kleemola M, Kuo CC, Saikku P. An epidemic of infections due to Chlamydia pneumonias in military conscripts. Clin Infect Dis. 1993;17:420-425.
51. Freidank HM, Brauer D. Prevalence of antibodies to Chlamydia pneumoniae TWAR in a group of German medical students. J Infect. 1993;27:89-93.
52. Grayston JT, Aldous MB, Easton A, Wang SP, Kuo CC, Campbell LA, Airman J. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis, y Infect Dis. 1993;168:1231-1235.
53. Kern DG, Neill MA, Schachter J. A seroepidemiologic study of Chlamydia pneitmoniae in Rhode Island: evidence of sérologie cross-reactivity. Chest. 1993:104:208-213.
54. Resta O, Monno R, Saracino A, Leone E, Gramiccione E, Fumarola D. Chlamydia pneumoniae infection in Italian patients. Monaldi Arch Chest Dis. 1995;50:173-176.
55. Thorn DH, Grayston JT, Campbell LA, Kuo CC, Diwan VK, Wang SP. Respiratory infection with Chlamydia pneitmoniae in middle-aged and older adult outpatients. EitrJ Clin Microbiol Infect Dis. 1994;13:785-792.
56. Grayston JT, Wang SP, Kuo CC, Campbell LA. Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. EitrJ Clin Microbiol Infect Dis. 1989;8:191-202.
57. Van den Abeele AM, van Renterghem L, Willems K, Plum J. Prevalence of antibodies to Chlamydia pneumoniae in a Belgian population. J Infect. 1992:25:87-90.
58. Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thorn DH, Wang SP. A new respiratory tract pathogen: Cltlamydia pneumoniae, strain TWAR.J Infect Dis. 1990:161:618-625.
59. Marrie TJ. Chlamydia pneumoniae. Tliorax. 1993:48:1-4.